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Background: Heart transplantation is limited by a severe donor organ shortage. Potential donors with brain death
(BD) and left ventricular dysfunction due to neurogenic stunning are currently excluded from donation – although
such abnormalities can be reversible with aggressive treatment including Hormonal Treatment (HT) and deferred
organ retrieval.
Aim: To assess the recovery of left ventricular dysfunction in potential brain-dead donors with hemodynamic
instability treated by aggressive treatment and HT.
Methods: In a single-center, observational study design, we evaluated 15 consecutive brain-dead potential donors
(DBD) (8 males, age = 48 ± 15 years) with hemodynamic instability. All underwent standard hemodynamic
monitoring and transthoracic 2-dimensional echo (2-DE) with assessment of Ejection Fraction (EF). Measurements
were obtained before BD and after BD within 6 h, at 24 h and within 48 h. HT (with insulin, methylprednisolone,
vasopressin and T3) was started as soon as possible to treat hemodynamic instability and avoid administration of
norepinephrine (NE). Eligible potential heart donors underwent coronary angiography.
Results: After HT, we observed a normalization of hemodynamic conditions with improvement of mean arterial
pressure (pre = 68 ± 8 mmHg vs post = 83 ± 13 mmHg, p< .01), cardiac index (pre = 2.4 ± 0.6 L/min/m2 vs post
3.7 ± 1.2 L/min/m2, p< .05), EF (pre = 48 ± 15 vs post = 59 ± 3%, p< .01) without administration of norepinephrine
(NE) in 67% of cases. Five potential donors were excluded from donation (opposition, n = 3, tubercolosis n = 1,
malignancy n = 1). At pre-harvesting angiography, coronary artery stenosis was present in 2 of the 10 consented
donors. Eight hearts were uneventfully transplanted. No early graft failure occurred and all eight recipients were
alive at 6-month follow-up.
Conclusion: In BD donors, intensive treatment including HT is associated with improvement of regional and global
LV function and reverse remodeling detectable by transthoracic 2DE. Donor hearts with recovered LV function may
be eligible for uneventful heart transplant. The wait (in brain death), treat (with HT) and see (with 2D echo) strategy
can help rescue organs suitable for heart donation.
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Heart transplantation is an established procedure in
end-stage heart failure patients, with satisfying long-
term results. However, this surgical therapy is continu-
ously limited by a severe donor organ shortage in recent
years. Therefore, adequate and optimal utilization of all
suitable donor organs is mandatory for increasing graft
availability [1]. Evidence exists that certain ‘standard’
donor criteria can be significantly liberalized to increase
the available donor pool by accepting ‘Marginal Donors’
who under conventional transplant guidelines would be
declined as potential organ donors [2]. If echocardiog-
raphy is the initial assessment investigation, the presence
of segmental wall motion abnormalities with abnormal
left ventricular ejection fraction in the absence of a his-
tory of heart disease is the single most common cause
for exclusion criteria for donation [3], according to
current eligibility criteria [4]. However, ventricular dys-
function may be transient [5], and arbitrary thresholds
of LV function may exclude hearts that could eventually
re-enter transplantable status. An early and aggressive Hor-
monal Treatment (HT), including triiodothyronine (T3),
vasopressin, insulin and methylprednisolone has been
proposed to manage unstable organ donors, particularly
when cardiac function is impaired [1,6]. This study aimed
to evaluate the effects of extended intensive treatment
including HT and deferred harvesting in potential organ
donors under conditions of hemodynamic instability.
Methods
From June 2010 through July 2011 we initially consid-
ered 27 consecutive brain-dead potential organ donors
(DBD) with cerebral lesions of different etiology, mostly
cerebral hemorrhage. Diagnosis of death was confirmed
by strict adherence to standardized neurological criteria
in accordance with Italian law and related guidelines. All
donors were managed according to international guide-
lines [1,6]. From the initial population of 27 patients, 12
patients with hemodynamic stability underwent organ
retrieval of eligible organs after brain death declaration
and were excluded from the study. Thus, the final study
population included 15 brain-dead patients, (8 men, 7
women; mean age 48 ± 15 years) under conditions of
hemodynamic instability despite adequate fluid filling
(Figure 1). The 15 potential donors were treated by HT
and organ retrieval was delayed to 24–48 h from brain
coning; retrieval was performed after legal declaration of
brain death [7]. Arterial blood pressure and cardiac out-
put were continuously monitored by the Vigileo/FloTrac
system (software version 1.01; Edwards Lifesciences,
Irvine, CA). Troponin values were recorded at brain
death and later. The hormonal resuscitation was started:
T3, 4 μg bolus + 1–3 μg /kg/h infusion; Vasopressin,
1 unit bolus + 0.5 – 4 U/h infusion; Methylprednisolone:15 mg/kg bolus; Insulin, 1U/hr (titrate glucose 120–
180 mg/dL) [8,9]. The hemodynamic management
included: the use of intravenous fluids to maintain mean
arterial pressure (MAP)> 60 mmHg, central venous
pressure (CVP) 4–12 mmHg and urine output 1–2 ml/
kg/h; correct anemia to maintain hemoglobin ≥ 10 g/dL;
electrolyte replacement; ventilator management to achieve
partial pressure of oxygen (PaO2)> 90 mm Hg; and pH in
the 7.35 to 7.45 range, dopamine< 10 μg/kg/min. Norepi-
nephrine was not administered, or infusion was weaned
as soon as possible. All potential heart donors underwent
an echocardiogram for evaluation of global ventricular
function according to American Society of Echocardiog-
raphy (ASE) recommendations [10]. The study complies
with the Declaration of Helsinki, and the study protocol
was submitted to the institutional ethics committee.
Echocardiographic analysis
All potential donors underwent transthoracic echocardi-
ography at baseline (within 6 h of brain death), and at
the end of the first and the second day of hormonal
treatment. We used commercially available equipment
(Mylab TM30 Gold Cardiovascular, Esaote, Italy) with a
P4-2 MHz transducer. Two Neuro-ICU anesthesiologists
trained in ultrasound performed the echocardiographic
exams and eyeballing ejection fraction was assessed
using apical 4- and 2-chamber views, adding a subcostal
approach when useful to improve the examination qual-
ity [11]. The saved 2D cine loops were transferred for a
later offline analysis using commercially available soft-
ware. One experienced cardiologist unaware of the iden-
tity of the patient and blinded to all clinical data and
previous readings estimated off-line the 2D LVEF by eye-
balling method, before, during and after HT.
Coronary angiography
Consented potential heart donors underwent coronary
angiography. Multiple angiographic views were obtained
for optimal visualization of the coronary arteries. For
each identifiable lesion, the angiographer determined
vessel diameter at the stenosis and at an adjacent angio-
graphically normal reference site to quantify the percent-
age of stenosis diameter. Focal and non-circumferential
atherosclerosis with 50% stenosis in proximal seg-
ments of at least one coronary vessel was regarded as
coronary atherosclerosis.
Transplant of eligible hearts
Eligible hearts (with normal echocardiography findings)
were retrieved using standard technique and preserved
with cold cardioplegic arrest and topical hypothermia
(Figure 1). All transplants were performed using the bica-
val anastomosis technique. Primary graft failure (PGF)
after heart transplant was defined as need for immediate
Figure 1 The study flow chart. TTE = transthoracic echocardiography, CA= coronary angiography.
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ents followed routine treatment and follow-up procedures.
Statistics
Software (SPSS 19 for Windows, SPSS, Chicago, Ill.,
USA) was used for statistical analysis. The statistical ana-
lyses included descriptive statistics (frequency and per-
centage of categorical variables and mean and standard
deviation of continuous variables). Pearson’s χ2 with
Fisher’s exact test for categorical variables and the
Mann–Whitney test for continuous variables for inter-
group comparisons were performed to confirm signifi-
cance (using the Monte Carlo method for small sample
comparisons).
Results
Demographic, echocardiographic, laboratory and hormo-
nal treatment data and outcome of individual potential
donors with hemodynamic instability are shown in
Table 1. The cause of death was cerebral hemorrhage in
nine cases, ischemic stroke in one case and head trauma
in five cases. Median maintenance time was 48 h (30–
156 h). Early increase in troponin was observed in 93%
(mean 3.36 ± 4.1 ng/mL) vs a final value of 0.48 ± 0.6
(p< 0.05 vs baseline). After HT, we observed a
normalization of hemodynamic conditions with a clear
improvement of systolic blood pressure (pre = 95 ±
10 mmHg vs post = 124± 15 mmHg, p< .01), mean
arterial pressure (pre = 68 ± 8 mmHg vs post = 83 ±13 mmHg, p< .01), cardiac index (pre= 2.4±0.6 L/min/m2
vs post 3.7 ± 1.2 L/min/m2, p< .05), peripheral arterial
blood lactate (pre = 3.2 ±1.8 vs post = 1.6 ± 0.7 mmol/L,
p< .01). In 10/15 cases norepinephrine was never used
after brain death; in 5/15 cases norepinephrine infusion
was stopped within 12 h. Transthoracic echocardiog-
raphy was feasible and interpretable in all brain-dead
potential donors.Echocardiographic data
A typical pattern of recovery is shown in Figure 2. The
patient showed severe left ventricular dysfunction and
dilation at study entry and full recovery after HT.
We observed a progressive improvement of indices of
global function (LVEF pre = 48 ± 15 % vs post = 59 ± 3%,
p< .01). At individual patient analysis, the improvement
was more obvious in six patients with worse function
at baseline (Figure 3). At segmental analysis, wall motion
abnormalities at study entry more often involved the
apical and septal (n = 2 ) walls, the global left ventricle
(n = 3), and the inferior wall in one case.Coronary angiography data
At pre-harvesting angiography, coronary artery stenosis
was present in two of the ten consented donors, both
with normal EF at study entry (Table 1). All consented
donors with abnormal LV function at study entry
showed normal coronary arteries at angiography. In one



















1 M 32 51 60 60 0.47 0.26 15 - Donor Yes 2 L-2 K-Li
2 F 54 30 60 60 3.27 0.50 15 - Donor Yes 2 K
3 M 66 56 60 60 2.82 0.87 15 12 Donor CAD 2 K-Li
4 M 51 30 55 55 0.99 0.64 12 - Donor CAD 2 K-Li
5 M 20 36 60 67 2.70 0.30 33 - Opposition - -
6 M 48 39 55 60 0.05 0.015 27 6 Donor Yes 2 L-2 K-Li-P
7 F 51 33 60 60 11.40 2.15 24 - Donor Yes 2 K-Li
8 F 56 72 60 60 5.61 0.25 63 - Donor Yes 2 K
9 F 45 48 37 55 0.23 0.21 9 - Donor Yes 2 K-Li
10 M 66 90 40 55 4.35 0.05 3 - Opposition - -
11 M 16 114 30 60 0.90 0.08 18 12 Opposition - -
12 F 64 69 40 60 2.17 - 27 12 Donor Yes 2 L-2 K-Li
13 F 56 48 20 54 13.80 0.90 12 - Tubercolosis - -
14 F 46 156 23 60 0.38 0.17 60 3 Donor Yes 2 K
15 M 50 42 55 58 1.32 0.30 3 - Malignancy - -
M=maintenance; CAD=Coronary Artery Disease; LVEF = Left Ventricular Ejection Fraction; T3 = Triiodothyronine; NE =Norepinephrine; Li = Liver; L = Lung;
K = Kidney; P = Pancreas.
Casartelli et al. Cardiovascular Ultrasound 2012, 10:25 Page 4 of 8
http://www.cardiovascularultrasound.com/content/10/1/25consented donor coronary angiography was not per-
formed because of the donor’s young age (32 years old).
Transplant eligibility
At the end of treatment all patients showed normal re-
gional and global LV function and were eligible for heart
donation. In patients with normal function at study
entry, five out of nine potential heart donors became
effective donors. The remaining four were excluded –
due to opposition in one, to coronary stenosis at angiog-
raphy in two and to malignancy in one. In patients with
abnormal function at study entry, three out of six poten-
tial heart donors became effective heart donors. The
remaining three were excluded for opposition in two,
tuberculosis in one. A total of eight consented hearts
without co-morbidities were uneventfully transplanted.
No early graft failure occurred and all eight recipients
were alive at 6-month follow-up.
Discussion
In Italy about 2300 patients per year are declared brain
dead, out of around 5500 dying in ICUs from acute dev-
astating cerebral lesions (i.e., brain trauma, hemorrhagic
or ischemic stroke and anoxia). Currently, brain-dead
consented organ donors number around 1100 with less
than 300 hearts transplanted per year (data from the
“Italian National Health Institute ”, 2011). This severe
shortage in transplantable heart status depends on eligi-
bility criteria based on the donor age, which is continu-
ously increasing, and functionality, which may be acutely
affected by the consequences of brain coning andhemodynamic instability. Thus, new strategies enhancing
functional recovery and reliable prediction of successful
heart transplantation are needed. In brain-dead potential
donors with hemodynamic instability, echocardiographic
serial assessment of LV function is feasible and shows,
in 40 % of patients, a moderate-to-severe alteration in
global and regional LV function. These alterations may
be fully reversible upon intensive care, in a couple of
days. In this setting, regional wall motion abnormalities
can occur in the absence of underlying coronary artery
stenoses, and also coronary artery stenoses can be
present with normal regional wall motion [12,13]. In this
single-center study, based on a limited number of poten-
tial donors, we showed that serial echocardiography is
feasible and interpretable in the extreme setting of DBD
potential donors, and at least as a proof-of-concept it
can be helpful, together with coronary angiography, in
selecting suitable heart donors otherwise dismissed on
the basis of the initial assessment. When initial LVEF is
impaired, the period of treatment after brain death can
be intentionally prolonged towards the golden time for
harvesting, facilitating recovery of stunned hearts and
eventually improving the quality of the graft before
transplantation. Early hormonal treatment may facilitate
complete weaning from vasopressors, and the recovery
of stunned hearts often occurs within the maintenance
period. These potential donors can manifest ECG abnor-
malities, hemodynamic instability, increased troponin
and left ventricular segmental wall motion abnormalities
mainly due to adrenergic storm and not to intrinsic car-
diac disease. However, according to current eligibility
Figure 2 Serial four chamber cineloops of a potential heart donor with hemodynamic instability. Left upper panel Normal LV function
before brain death. Right upper panel. Takotsubo-like LV dysfunction immediately after subarachnoid hemorrhage and brain death:
echocardiographically detected left ventricular systolic dysfunction excludes this heart from transplant according to standard criteria. Left lower
panel Reduction of end-systolic volume and improved systolic thickening. One day after early and aggressive hormonal treatment, including
triiodothyronine, vasopressin, insulin and methylprednisolone with improvement of heart function. Right lower panel. Two days after hormonal
treatment the heart definitively normalized, was retrieved and was successfully transplanted. An additional movie file shows this in more detail
[see Additional file 1].
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abnormalities of the left ventricle is an exclusion criter-
ion for donation. In a large subset of brain-dead donor
hearts left ventricular performance is reduced because
the myocardium is regionally stunned or hibernating
rather than irreversibly infarcted or fibrotic [12,13]. The
detection of reversible dysfunctional myocardium is clin-
ically relevant, as regional or global left ventricular func-
tion will improve after transplant [14,15]. Such recovery
can be facilitated, elicited by cardiovascular targeted in-
tensive treatment, including hormonal treatment and
noradrenaline sparing strategy, lasting until 24–48 h
before harvesting [8-10,16,17]. Thus, the challenge is
to identify markers that indicate which hearts are likely
to have good function or be treated to satisfactory
hemodynamic status and transplantation suitability.
Serial echocardiography in the stunned brain-dead
potential donor
Standard rest echocardiography is a non-invasive, port-
able, and rapidly available investigation that is ideally
suited to the accurate assessment of donor ventricularfunction. However, in the presence of left ventricular
dysfunction, a “single spot” echocardiography does not
predict reversibility or non-reversibility of ventricular
function after heart transplant [14]. If echocardiography
is the initial assessment investigation, echocardiographi-
cally detected left ventricular systolic dysfunction in the
absence of a history of heart disease is the single most
common cause for non-transplantation of an organ [15].
However, ventricular dysfunction may be transient [14],
occurs in 10% to 42% of donor hearts, and arbitrary
thresholds of LV function may exclude hearts that could
be resuscitated to transplantable status. Such limitations
can be overcome with serial evaluations allowing us to
identify those hearts with reversible dysfunction that
may recover transplantation status.
Hormonal treatment in the stunned brain-dead
potential donor
The brainstem ischemia occurring in the terminal phase
of the pathophysiological process which leads to brain
death may cause an “autonomic storm” with inten-
sive sympathetic nervous system activity, followed by
Figure 3 The values of left ventricular ejection fraction at study
entry (Early LVEF %), and following 2 days (Final LVEF %) of
hormonal treatment. At individual potential donor analysis, the
improvement was more obvious in hearts with worse function
at baseline.
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be exacerbated by changes in endocrine homeostasis,
metabolism, and the development of a proinflammatory
state. In patients with subarachnoid hemorrhage, the
catecholamine surge occurring at the time of cerebral
bleeding may cause a severe cardiac and pulmonary
reversible dysfunction. Similarly, the intensive sympa-
thetic activity and catecholamine release associated
with brain death may result in severe myocardial dys-
function [5] originating from multiple factors: calcium
overload [18], a possible reduction in high-energy phos-
phates [19], beta-adrenoreceptor desensitization, endo-
thelial damage [19,20], and altered gene expression.
Further decreased thyroid hormone (especially T3, insu-
lin, and cortisol levels) are seen [13]. Pituitary failure
produces abnormal temperature homeostasis, and even-
tually a catecholamine-deficient vasoparetic state occurs.
All these phenomena may further affect cardiac function.
Impact of ‘optimal donor management’
Management of ‘marginal’ hearts should include donor
graft ‘resuscitation’ and re-evaluation [3,5], thus allowing
potential organ rescue and utilization. Many authors and
guidelines [6] support treatment with insulin, corticos-
teroids [21], T3 [22] and arginine vasopressin [23] which
may improve ventricular performance, raise systolic
blood pressure and reduce inotropic requirements,
obtaining early and sufficient circulatory stabilization.
Published controlled studies do not support HT treat-
ment in stable potential donors but other prospective
results are needed to investigate HT effects in
hemodynamically unstable donors, considering longer
duration of treatment [24]. However, in non-randomized
clinical studies, organs that were at first glance assessedas marginal and/or unacceptable had the potential to
improve with such an integrated approach and thus be
utilized, resulting in an increase of utilization rates from
only 39% to 58% [21], with excellent results in experi-
enced centers.
Study limitations
This is a single-center experience with a relatively low
sample size. In addition, the observational, not rando-
mized, study design does not allow us to separate the
effects of HT (treat-wait-and-see) vs simple wait-and-see
strategy on the observed benefit. In fact, neurogenic
stunning can also spontaneously disappear with time, as
clearly shown in patients with subarachnoid hemorrhage
and Takotsubo cardiomyopathy [13]. We used visual
assessment of left ventricular ejection fraction (LVEF)
despite general recommendations to use quantitative
biplane Simpsons (BPS) measurements. Although quan-
titative methods are well-validated and to be preferred in
a research-oriented setting, visual assessment (eyebal-
ling) is unquestionably easier and faster, and possibly
even more accurate, especially in a technically demand-
ing clinical setting such as the neurological intensive
care unit with brain dead potential donors, with poor
image quality, and when a well-trained observer blinded
to the study condition performs the analysis [11].
Clinical implications
This study shows that it is possible to provide long
maintenance periods based on high quality intensive
care management without losing the possibility of organ
retrieval. Consequently, the concept of “maintenance” of
potential organ donors could be extended to “treatment”
of a malfunctioning graft in the potential donor before
organ retrieval. Larger, multicenter, prospective studies
are needed to evaluate the effects of hormonal treatment
and timing on potential organ donors under conditions
of hemodynamic instability. This approach can be added
to other strategies proposed to expand the heart donor
pool, such as the ADONHERS project, with stress echo-
driven selection of old donor hearts for heart transplant-
ation [25-28]. Using stress echo, ADONHERS recruits
hearts previously excluded from transplantation due to
advanced age, whereas the approach proposed here
utilizes serial TTE to rescue hearts previously excluded
for resting left ventricular wall motion abnormalities.
At least in theory, the stress echo approach might also
be applied to these potential heart donors with left ven-
tricular abnormalities, since viability response during
stress echo effectively recognizes viable tissue with non-
fixed response, as opposed to necrotic response with
scar and fixed wall motion abnormalities following
inotropic challenge with either dobutamine or dipyrid-
amole [29]. Information on resting function, viability
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pharmacologic stress echocardiography in a bedside,
low-cost, and radiation-free approach [30].
Donor hearts with recovered LV function can be
eligible for uneventful heart transplant. A strategy based
on a) longer interval of maintenance of the brain-dead
potential donor (wait), b) a circulatory targeted treat-
ment including HT (treat) and c) heart function moni-
toring by 2D echo (see) can help to rescue organs
suitable for heart donation.
Additional file
Additional file 1: Title of data. Serial four chamber cineloops
of a potential heart donor with hemodynamic instability. Description of
data: Left upper panel Normal LV function before brain death.
Right upper panel. Takotsubo-like LV dysfunction immediately after
subarachnoid hemorrhage and brain death: echocardiographically
detected left ventricular systolic dysfunction excludes this heart from
transplant according to standard criteria. Left lower panel Reduction of
end-systolic volume and improved systolic thickening. One day after
early and aggressive hormonal treatment, including triiodothyronine,
vasopressin, insulin and methylprednisolone with improvement of
heart function. Right lower panel. Two days after hormonal
treatment the heart definitively normalized, was retrieved and was
successfully transplanted.
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